These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structural domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation. Chen Z; Jones LR; O'Brian JJ; Moorman JR; Cala SE Circ Res; 1998 Feb; 82(3):367-74. PubMed ID: 9486665 [TBL] [Abstract][Full Text] [Related]
5. Emerging issues of connexin channels: biophysics fills the gap. Harris AL Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236 [TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions in the FXYD motif enhance phospholemman-induced modulation of cardiac L-type calcium channels. Guo K; Wang X; Gao G; Huang C; Elmslie KS; Peterson BZ Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1203-11. PubMed ID: 20720179 [TBL] [Abstract][Full Text] [Related]
7. A single P-loop glutamate point mutation to either lysine or arginine switches the cation-anion selectivity of the CNGA2 channel. Qu W; Moorhouse AJ; Chandra M; Pierce KD; Lewis TM; Barry PH J Gen Physiol; 2006 Apr; 127(4):375-89. PubMed ID: 16533895 [TBL] [Abstract][Full Text] [Related]
8. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. Morrison BW; Moorman JR; Kowdley GC; Kobayashi YM; Jones LR; Leder P J Biol Chem; 1995 Feb; 270(5):2176-82. PubMed ID: 7836447 [TBL] [Abstract][Full Text] [Related]
9. Regulation of L-type calcium channel by phospholemman in cardiac myocytes. Zhang XQ; Wang J; Song J; Rabinowitz J; Chen X; Houser SR; Peterson BZ; Tucker AL; Feldman AM; Cheung JY J Mol Cell Cardiol; 2015 Jul; 84():104-11. PubMed ID: 25918050 [TBL] [Abstract][Full Text] [Related]
10. Modulation of Xenopus oocyte-expressed phospholemman-induced ion currents by co-expression of protein kinases. Mounsey JP; Lu KP; Patel MK; Chen ZH; Horne LT; John JE; Means AR; Jones LR; Moorman JR Biochim Biophys Acta; 1999 Sep; 1451(2-3):305-18. PubMed ID: 10556585 [TBL] [Abstract][Full Text] [Related]
11. The calcium-binding EF-hand in polycystin-L is not a domain for channel activation and ensuing inactivation. Li Q; Liu Y; Zhao W; Chen XZ FEBS Lett; 2002 Apr; 516(1-3):270-8. PubMed ID: 11959145 [TBL] [Abstract][Full Text] [Related]
12. Volume sensitive efflux of taurine in HEK293 cells overexpressing phospholemman. Morales-Mulia M; Pasantes-Morales H; MorĂ¡n J Biochim Biophys Acta; 2000 Apr; 1496(2-3):252-60. PubMed ID: 10771093 [TBL] [Abstract][Full Text] [Related]
13. A study of the membrane association and regulatory effect of the phospholemman cytoplasmic domain. Hughes E; Whittaker CA; Barsukov IL; Esmann M; Middleton DA Biochim Biophys Acta; 2011 Apr; 1808(4):1021-31. PubMed ID: 21130070 [TBL] [Abstract][Full Text] [Related]
15. Dominant-negative suppression of big brain ion channel activity by mutation of a conserved glutamate in the first transmembrane domain. Yool AJ Gene Expr; 2007; 13(6):329-37. PubMed ID: 17708419 [TBL] [Abstract][Full Text] [Related]
16. Effects of phospholemman expression on swelling-activated ion currents and volume regulation in embryonic kidney cells. Davis CE; Patel MK; Miller JR; John JE; Jones LR; Tucker AL; Mounsey JP; Moorman JR Neurochem Res; 2004 Jan; 29(1):177-87. PubMed ID: 14992277 [TBL] [Abstract][Full Text] [Related]
17. Impact of phosphomimetic and non-phosphorylatable mutations of phospholemman on L-type calcium channels gating in HEK 293T cells. Guo K; Wang YP; Zhou ZW; Jiang YB; Li W; Chen XM; Li YG J Cell Mol Med; 2015 Mar; 19(3):642-50. PubMed ID: 25656605 [TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane. Lansbery KL; Burcea LC; Mendenhall ML; Mercer RW Am J Physiol Cell Physiol; 2006 May; 290(5):C1275-86. PubMed ID: 16371442 [TBL] [Abstract][Full Text] [Related]
19. Phospholemman expression induces a hyperpolarization-activated chloride current in Xenopus oocytes. Moorman JR; Palmer CJ; John JE; Durieux ME; Jones LR J Biol Chem; 1992 Jul; 267(21):14551-4. PubMed ID: 1378834 [TBL] [Abstract][Full Text] [Related]
20. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating. Moorhouse AJ; Jacques P; Barry PH; Schofield PR Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]